|
TPRKB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.51930000381296E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.83770000018147E-07 |
| Normal-vs-Stage2 |
1.579910E-03 |
| Normal-vs-Stage3 |
3.431500E-02 |
| Normal-vs-Stage4 |
1.367560E-01 |
| Stage1-vs-Stage2 |
5.384400E-01 |
| Stage1-vs-Stage3 |
5.634400E-01 |
| Stage1-vs-Stage4 |
9.592600E-01 |
| Stage2-vs-Stage3 |
3.546000E-01 |
| Stage2-vs-Stage4 |
6.624200E-01 |
| Stage3-vs-Stage4 |
7.874200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.7504999984026E-08 |
| Normal-vs-AfricanAmerican |
3.641000E-04 |
| Normal-vs-Asian |
9.755100E-04 |
| Caucasian-vs-AfricanAmerican |
6.598000E-01 |
| Caucasian-vs-Asian |
6.778600E-01 |
| AfricanAmerican-vs-Asian |
5.766600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.00739999967459E-07 |
| Normal-vs-Female |
1.74760999999135E-05 |
| Male-vs-Female |
3.078400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.755200E-04 |
| Normal-vs-Extreme_Weight |
1.94959999999522E-06 |
| Normal-vs-Obese |
1.841080E-04 |
| Normal-vs-Extreme_Obese |
1.297620E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.872600E-01 |
| Normal_Weight-vs-Obese |
4.952600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.658800E-01 |
| Extreme_Weight-vs-Obese |
3.304400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.714400E-01 |
| Obese-vs-Extreme_Obese |
1.710980E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.551700E-02 |
| Normal-vs-Age(41-60Yrs) |
8.58770000000675E-07 |
| Normal-vs-Age(61-80Yrs) |
4.20270000001111E-06 |
| Normal-vs-Age(81-100Yrs) |
2.174000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.738200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.985600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.764000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.580600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.263800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.539800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.28020039014132E-10 |
| Normal-VS-Type2 PRCC |
1.107880E-02 |
| Normal-VS-KIRP CIMP |
6.462600E-01 |
| Normal-VS-Unclassified PRCC |
1.078950E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.677900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.893510E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
3.123300E-03 |
| Type2 PRCC-VS-KIRP CIMP |
3.801200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
5.921000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.302000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.056500E-03 |
| Normal-vs-N1 |
3.974400E-02 |
| Normal-vs-N2 |
5.822800E-01 |
| N0-vs-N1 |
9.656400E-01 |
| N0-vs-N2 |
9.241800E-01 |
| N1-vs-N2 |
9.111800E-01 |
|
|
